Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a supplemental notice to its 2023 AGM, maintaining the original date and location for the meeting on June 20, 2024, and proposing additional resolutions, including the appointment of Mr. LAI Degui as a non-executive Director and amendments to the articles of association following the resignation of Supervisors. Shareholders are advised to review the revised proxy form and supplemental circular for further details on the new resolutions and proxy arrangements.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.